These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3142824)

  • 1. Case history: successful thrombolytic therapy in a patient with acute myocardial infarction.
    Sait YR
    Heart Lung; 1988 Nov; 17(6 Pt 2):782-6. PubMed ID: 3142824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic therapy with tissue-type plasminogen activator].
    Toma M; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical application of intravenous thrombolytic therapy in acute myocardial infarction].
    Kanmatsuse K; Kajiwara N
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1213-7. PubMed ID: 1431461
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue plasminogen activator in pediatric myocardial infarction.
    Krendel S; Pollack P; Hanly J
    Ann Emerg Med; 2000 May; 35(5):502-5. PubMed ID: 10783412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic hemorrhage: a complication of tissue plasminogen activator treatment.
    Cheung PK; Arnold JM; McLarty TD
    Can J Cardiol; 1990 Jun; 6(5):183-5. PubMed ID: 2116935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction].
    Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M
    Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant tissue-type plasminogen activator in acute myocardial infarction: role of the critical care nurse.
    Kline EM
    Heart Lung; 1987 Nov; 16(6 Pt 2):779-86. PubMed ID: 2960639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reinfarction after thrombolytic therapy. Results obtained with readministration of thrombolytic agent in 3 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1993 Mar; 60(3):177-82. PubMed ID: 8250747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 13. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction].
    Uto K; Ota Y; Mizuno M; Nakamura A; Nakajima R; Endoh Y; Kasanuki H
    J Cardiol; 2002 Dec; 40(6):241-8. PubMed ID: 12528645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myocardial infarction and coronary thrombolysis].
    Kanmatsuse K
    Rinsho Ketsueki; 1996 Sep; 37(9):813-6. PubMed ID: 8914468
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.
    Becker RC; Corrao JM; Harrington R; Ball SP; Gore JM
    Am Heart J; 1991 Jan; 121(1 Pt 1):220-44. PubMed ID: 1898680
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for myocardial infarction.
    Andreotti F
    N Engl J Med; 1998 Feb; 338(8):546; author reply 547. PubMed ID: 9471558
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Front-loaded infusion therapy of rT-PA during active menstruation. A case report.
    Lee DW; Garza JL
    Angiology; 1994 Apr; 45(4):311-4. PubMed ID: 8161010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.